rabbit polyclonal anti trpm8 antibody (Novus Biologicals)
Structured Review
Rabbit Polyclonal Anti Trpm8 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+trpm8/TRPM8+Antibody+-+BSA+Free/pm41688418-379-9-18
Average 93 stars, based on 13 article reviews
Images
Related Articles
other:Article Title: Therapeutic potential of TRPM8 antagonists in prostate cancer Article Snippet: TRPM8 was detected using the Article Title: Therapeutic potential of TRPM8 antagonists in prostate cancer. Article Snippet: TRPM8 was detected using the Western Blot:Article Title: New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. Article Snippet: TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have been proposed as potential anticancer agents in this pathology.. We have recently demonstrated their effectiveness in a castration-resistant prostate cancer (CRPC) model that is usually resistant to androgen deprivation therapy (ADT) and is considered the most aggressive form of PC.. This is why the discovery of selective, effective, and potent TRPM8 modulators would improve the molecular arsenal in support of PC standard-of-care treatments. Analysis:Article Title: New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. Article Snippet: TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have been proposed as potential anticancer agents in this pathology.. We have recently demonstrated their effectiveness in a castration-resistant prostate cancer (CRPC) model that is usually resistant to androgen deprivation therapy (ADT) and is considered the most aggressive form of PC.. This is why the discovery of selective, effective, and potent TRPM8 modulators would improve the molecular arsenal in support of PC standard-of-care treatments. |



